Report Detail

Medical Devices & Consumables Global Passive Digital Biomarker Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4681135
  • |
  • 26 February, 2026
  • |
  • Global
  • |
  • 120 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Passive Digital Biomarker market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Passive digital biomarkers are individual biological and behavioral data collected passively (passively) through digital technologies, sensors, and smart devices. These data can include physiological parameters (e.g., heart rate, sleep quality, exercise), behavioral activities (e.g., walking, daily activities), environmental factors (e.g., ambient temperature, air quality), etc.
This report is a detailed and comprehensive analysis for global Passive Digital Biomarker market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Passive Digital Biomarker market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Passive Digital Biomarker market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Passive Digital Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Passive Digital Biomarker market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Passive Digital Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Passive Digital Biomarker market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Philips, Novartis, Johnson & Johnson, GlaxoSmithKline, GE Healthcare, Asahi Kasei, Abbott Laboratories, Merck, Bayer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Passive Digital Biomarker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Physiological Parameters Type
Behavioral Activity Type
Environmental Factors Type
Others
Market segment by Application
Health Management
Disease Prevention
Clinical Diagnosis
Others
Major players covered
Pfizer
Philips
Novartis
Johnson & Johnson
GlaxoSmithKline
GE Healthcare
Asahi Kasei
Abbott Laboratories
Merck
Bayer
Sanofi
Koneksa Health
Huma Therapeutics
Roche
Biogen
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Passive Digital Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Passive Digital Biomarker, with price, sales quantity, revenue, and global market share of Passive Digital Biomarker from 2021 to 2026.
Chapter 3, the Passive Digital Biomarker competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Passive Digital Biomarker breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Passive Digital Biomarker market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Passive Digital Biomarker.
Chapter 14 and 15, to describe Passive Digital Biomarker sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Passive Digital Biomarker Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Physiological Parameters Type
    • 1.3.3 Behavioral Activity Type
    • 1.3.4 Environmental Factors Type
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Passive Digital Biomarker Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Health Management
    • 1.4.3 Disease Prevention
    • 1.4.4 Clinical Diagnosis
    • 1.4.5 Others
  • 1.5 Global Passive Digital Biomarker Market Size & Forecast
    • 1.5.1 Global Passive Digital Biomarker Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Passive Digital Biomarker Sales Quantity (2021-2032)
    • 1.5.3 Global Passive Digital Biomarker Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Passive Digital Biomarker Product and Services
    • 2.1.4 Pfizer Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Philips
    • 2.2.1 Philips Details
    • 2.2.2 Philips Major Business
    • 2.2.3 Philips Passive Digital Biomarker Product and Services
    • 2.2.4 Philips Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Philips Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Passive Digital Biomarker Product and Services
    • 2.3.4 Novartis Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson Passive Digital Biomarker Product and Services
    • 2.4.4 Johnson & Johnson Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Johnson & Johnson Recent Developments/Updates
  • 2.5 GlaxoSmithKline
    • 2.5.1 GlaxoSmithKline Details
    • 2.5.2 GlaxoSmithKline Major Business
    • 2.5.3 GlaxoSmithKline Passive Digital Biomarker Product and Services
    • 2.5.4 GlaxoSmithKline Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 GlaxoSmithKline Recent Developments/Updates
  • 2.6 GE Healthcare
    • 2.6.1 GE Healthcare Details
    • 2.6.2 GE Healthcare Major Business
    • 2.6.3 GE Healthcare Passive Digital Biomarker Product and Services
    • 2.6.4 GE Healthcare Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GE Healthcare Recent Developments/Updates
  • 2.7 Asahi Kasei
    • 2.7.1 Asahi Kasei Details
    • 2.7.2 Asahi Kasei Major Business
    • 2.7.3 Asahi Kasei Passive Digital Biomarker Product and Services
    • 2.7.4 Asahi Kasei Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Asahi Kasei Recent Developments/Updates
  • 2.8 Abbott Laboratories
    • 2.8.1 Abbott Laboratories Details
    • 2.8.2 Abbott Laboratories Major Business
    • 2.8.3 Abbott Laboratories Passive Digital Biomarker Product and Services
    • 2.8.4 Abbott Laboratories Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Abbott Laboratories Recent Developments/Updates
  • 2.9 Merck
    • 2.9.1 Merck Details
    • 2.9.2 Merck Major Business
    • 2.9.3 Merck Passive Digital Biomarker Product and Services
    • 2.9.4 Merck Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Merck Recent Developments/Updates
  • 2.10 Bayer
    • 2.10.1 Bayer Details
    • 2.10.2 Bayer Major Business
    • 2.10.3 Bayer Passive Digital Biomarker Product and Services
    • 2.10.4 Bayer Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bayer Recent Developments/Updates
  • 2.11 Sanofi
    • 2.11.1 Sanofi Details
    • 2.11.2 Sanofi Major Business
    • 2.11.3 Sanofi Passive Digital Biomarker Product and Services
    • 2.11.4 Sanofi Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sanofi Recent Developments/Updates
  • 2.12 Koneksa Health
    • 2.12.1 Koneksa Health Details
    • 2.12.2 Koneksa Health Major Business
    • 2.12.3 Koneksa Health Passive Digital Biomarker Product and Services
    • 2.12.4 Koneksa Health Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Koneksa Health Recent Developments/Updates
  • 2.13 Huma Therapeutics
    • 2.13.1 Huma Therapeutics Details
    • 2.13.2 Huma Therapeutics Major Business
    • 2.13.3 Huma Therapeutics Passive Digital Biomarker Product and Services
    • 2.13.4 Huma Therapeutics Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Huma Therapeutics Recent Developments/Updates
  • 2.14 Roche
    • 2.14.1 Roche Details
    • 2.14.2 Roche Major Business
    • 2.14.3 Roche Passive Digital Biomarker Product and Services
    • 2.14.4 Roche Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Roche Recent Developments/Updates
  • 2.15 Biogen
    • 2.15.1 Biogen Details
    • 2.15.2 Biogen Major Business
    • 2.15.3 Biogen Passive Digital Biomarker Product and Services
    • 2.15.4 Biogen Passive Digital Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Biogen Recent Developments/Updates

3 Competitive Environment: Passive Digital Biomarker by Manufacturer

  • 3.1 Global Passive Digital Biomarker Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Passive Digital Biomarker Revenue by Manufacturer (2021-2026)
  • 3.3 Global Passive Digital Biomarker Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Passive Digital Biomarker by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Passive Digital Biomarker Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Passive Digital Biomarker Manufacturer Market Share in 2025
  • 3.5 Passive Digital Biomarker Market: Overall Company Footprint Analysis
    • 3.5.1 Passive Digital Biomarker Market: Region Footprint
    • 3.5.2 Passive Digital Biomarker Market: Company Product Type Footprint
    • 3.5.3 Passive Digital Biomarker Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Passive Digital Biomarker Market Size by Region
    • 4.1.1 Global Passive Digital Biomarker Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Passive Digital Biomarker Consumption Value by Region (2021-2032)
    • 4.1.3 Global Passive Digital Biomarker Average Price by Region (2021-2032)
  • 4.2 North America Passive Digital Biomarker Consumption Value (2021-2032)
  • 4.3 Europe Passive Digital Biomarker Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Passive Digital Biomarker Consumption Value (2021-2032)
  • 4.5 South America Passive Digital Biomarker Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Passive Digital Biomarker Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Passive Digital Biomarker Sales Quantity by Type (2021-2032)
  • 5.2 Global Passive Digital Biomarker Consumption Value by Type (2021-2032)
  • 5.3 Global Passive Digital Biomarker Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Passive Digital Biomarker Sales Quantity by Application (2021-2032)
  • 6.2 Global Passive Digital Biomarker Consumption Value by Application (2021-2032)
  • 6.3 Global Passive Digital Biomarker Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Passive Digital Biomarker Sales Quantity by Type (2021-2032)
  • 7.2 North America Passive Digital Biomarker Sales Quantity by Application (2021-2032)
  • 7.3 North America Passive Digital Biomarker Market Size by Country
    • 7.3.1 North America Passive Digital Biomarker Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Passive Digital Biomarker Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Passive Digital Biomarker Sales Quantity by Type (2021-2032)
  • 8.2 Europe Passive Digital Biomarker Sales Quantity by Application (2021-2032)
  • 8.3 Europe Passive Digital Biomarker Market Size by Country
    • 8.3.1 Europe Passive Digital Biomarker Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Passive Digital Biomarker Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Passive Digital Biomarker Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Passive Digital Biomarker Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Passive Digital Biomarker Market Size by Region
    • 9.3.1 Asia-Pacific Passive Digital Biomarker Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Passive Digital Biomarker Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Passive Digital Biomarker Sales Quantity by Type (2021-2032)
  • 10.2 South America Passive Digital Biomarker Sales Quantity by Application (2021-2032)
  • 10.3 South America Passive Digital Biomarker Market Size by Country
    • 10.3.1 South America Passive Digital Biomarker Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Passive Digital Biomarker Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Passive Digital Biomarker Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Passive Digital Biomarker Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Passive Digital Biomarker Market Size by Country
    • 11.3.1 Middle East & Africa Passive Digital Biomarker Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Passive Digital Biomarker Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Passive Digital Biomarker Market Drivers
  • 12.2 Passive Digital Biomarker Market Restraints
  • 12.3 Passive Digital Biomarker Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Passive Digital Biomarker and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Passive Digital Biomarker
  • 13.3 Passive Digital Biomarker Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Passive Digital Biomarker Typical Distributors
  • 14.3 Passive Digital Biomarker Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Passive Digital Biomarker. Industry analysis & Market Report on Passive Digital Biomarker is a syndicated market report, published as Global Passive Digital Biomarker Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Passive Digital Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report